Tag: NICE
Vascular Society comments on NICE AAA guidelines
On 15 April 2020, the Vascular Society of Great Britain and Ireland (Vascular Society) issued a comment on the recently published UK National Institute...
NICE aortic guidelines recommend discussion between physician and patient before offering...
The UK National Institute for Health and Care Excellence (NICE) has today published guidelines on abdominal aortic aneurysm (AAA) diagnosis and management. Discussion between...
CX 2020 encourages vascular community to strive for consensus
The Charing Cross Symposium (CX; 21–24 April, London, UK) is the longest-running vascular and endovascular global symposium, and an important source of Education, Innovation,...
NICE evidence review finds VAC VERAFLO superior to standard care in...
3M has announced that the UK National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing (MIB) regarding the use...
EVAR before, and EVAR after: VEITHtv looks back with the pioneers
Enrico Ascher (New York, USA) interviews endovascular pioneers Juan Parodi (Buenos Aires, Argentina) and Frank Veith (New York, USA) about the early days of endovascular aortic...
VSASM 2019: “Extreme care” needed not to overgeneralise when creating AAA...
Jan Blankensteijn (Amsterdam, Netherlands) talks to BLearning Aortic at VSASM 2019 (Vascular Societies’ Annual Scientific Meeting; 27–29 November, Manchester, UK) following his Kinmonth Lecture presentation titled ‘The current...
Guidelines director at NICE faces questions on AAA uncertainty
Paul Chrisp, the director of the Centre for Guidelines at the National Institute for Health and Care Excellence (NICE), spoke at the annual meeting...
Ian Loftus
Ian Loftus talks to Vascular News about various aspects of his professional life, from a surgical placement that inspired his career path through to...
Benefit of EVAR for rAAA will be lost if elective EVAR...
At the first London Aorta meeting, a collaborative association between the London Aorta Masterclass and the London Aortic Symposium, held 10–11 October in London,...
NICE abdominal aortic aneurysm guideline takes an “unprecedented” turn
Ian Loftus (London, UK), president of the Vascular Society for Great Britain and Ireland, tells BLearning about the most recent developments in the UK’s...
“Urgent action is required for patients with venous ulceration”
Despite what current guidelines denote, and in addition to the emergence of data supporting the early intervention of venous ulceration, Alun Davies (London, UK)...
EVAR funding threatened, while strategy for safe, cost-effective repair is “just...
The durability of endovascular aneurysm repair (EVAR) is in the limelight as the UK vascular community awaits the final aortic aneurysm guidelines from the...
European vascular community continues to dispute draft NICE AAA guidelines amidst...
At a session dedicated to the draft abdominal aortic aneurysm (AAA) guidelines put forward by the UK’s National Institute of Health and Care Excellence...
Draft NICE aortic guidelines cause endovascular controversy
For the vascular community in the UK, discourse on guidelines in 2018 increasingly came to focus on the proposed guidelines document from the National...
Open vs. endovascular aneurysm repair in the 60-year-old man against the...
“The best treatment for a 60-year-old man with an infrarenal abdominal aortic aneurysm that is above the threshold for intervention is arguably surgery based...
Individual evaluation of each patient, and each aorta, is key to...
“The instructions for use (IFU) are not a clinical guideline, so trainees should really think about what the main considerations are when they are...
NICE draft guideline casts shadow over EVAR for unruptured aneurysms
The UK’s National Institute for Health and Care Excellence (NICE) has issued draft guidance on abdominal aortic aneurysm (AAA) diagnosis and management. The most...
NICE collaborates with US FDA on Payer Communication Taskforce
The UK’s National Institute for Health and Care Excellence (NICE) has announced its participation in the US Food and Drug Administration (FDA)’s Payer Communication...
